Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
CYT | Cyteir Therapeutics, Inc. | Chief Business Officer | $124K | Feb 22, 2022 | ||
ATHA | Athira Pharma, Inc. | CFO and Chief Business Officer | $55.2K | -$720 | -1.29% | Sep 3, 2024 |
TERN | Terns Pharmaceuticals, Inc. | Chief Financial Officer | Feb 24, 2025 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|